As of 26 Oct 2026, KK Shah Hospitals is loss-making on a trailing 12-month basis, with a net loss of ₹0.08 Cr, so it has no P/E ratio. The share price is ₹45.00, 13% below its 52-week high. Sales grew 64% a year over 3 years. It is a small-cap company with a market cap of ₹31 Cr; the shares rose 3.9% over the past year.
- ₹45.00
- ₹45.00
- ₹45.00
- ₹45.00
- 6K
Health check
- ReturnsModest
+3.9% over the past year.
- Price tagLoss-making
Earnings were negative over the last 12 months.
- GrowthUnder pressure
Sales +64.5% a year over 3 years, but loss-making now.
- ProfitabilityNegative
ROCE -5.7%.
- Balance sheetn/a
Balance sheet figures aren’t reported.
- Red flags2 to check
Loss-making over the last twelve months.
Small cap
Market sensitivity
Key metrics
- Market cap
- ₹31 Cr
- Small cap
- P/E
- n/a
- Price to book
- 2.32
- Book value ₹19.36
- Dividend yield
- 0.00%
- ROE
- −0.6%
- Return on equity
- ROCE
- −5.7%
- Return on capital employed
- Debt to equity
- n/a
- Debt ₹0.00 Cr
- EPS (TTM)
- −₹0.91
- OPM (TTM)
- 2.1%
- Net margin −0.7%
- Sales growth
- +15.0%
- Latest quarter vs a year ago
- Profit growth
- n/a
- Year-ago quarter not reported
- Price to sales
- 3.02
- EV/EBITDA 28.0
Strengths and risks
Strengths
- Quarterly sales up 15.0% on a year ago.
Risks to check
- Loss-making over the last twelve months.
- Return on equity is low at −0.6%.
About KK Shah Hospitals
KK Shah Hospitals Limited provides healthcare services in India. It provides services in the areas of general surgery, orthopaedics, obstetrics and gynecology, dental, general medicine, ambulance services, pediatrics, accident and emergency, ICU, physiotherapy, radiology, and ophthalmology services, as well as robotic knee replacement surgery. The company was formerly known as Jeevan Parv Healthcare Limited and changed its name to KK Shah Hospitals…
- Headquarters
- Ratlam
- Employees
- 77
- Sector
- Healthcare
- ISIN
- INE0OH401016
- Website
- shahhospitalratlam.com
Price range
- Avg volume (3M)
- 2.5K
- 1-year return
- plus 3.9%
- From 52-week high
- minus 13.3%
Peers
We couldn’t find listed peers for this company.
Quarterly results
This company doesn’t report these figures in a format we can read yet.
Profit & loss
- Sales CAGR 3Y
- +64.5%
- ROE
- −0.6%
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 2.1 | 6.9 | 9 | 9.4 | |
| – | +224.7% | +30.8% | +4.8% | |
| 1.8 | 6.3 | 8.9 | 8.7 | |
| 0.4 | 0.6 | 0.1 | 0.8 | |
| 17.3% | 8.7% | 1.5% | 8.1% | |
| 0 | 0.5 | 0.6 | 0.2 | |
| 0 | – | – | – | |
| 0.1 | 0.4 | 1 | 1.7 | |
| 0.3 | 0.7 | −0.3 | −0.7 | |
| 25.2% | 12.9% | −0.2% | 14.5% | |
| 0.2 | 0.6 | −0.3 | −0.6 | |
| – | +178.4% | minus 153.9% | – | |
| 0.32 | 1.07 | -0.48 | – |
Forecast
Balance sheet
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 4.9 | 6.8 | 6.8 | 6.8 | |
| 0.2 | 7.3 | 6.6 | 6 | |
| 0.5 | 0.5 | 2.6 | 2.2 | |
| 5.6 | 14.6 | 16 | 15 | |
| 1.3 | 1.9 | 7.8 | 12.7 | |
| – | 0.6 | – | 6.2 | |
| 2 | 10.4 | 6.5 | 0.6 | |
| 2 | 0.8 | 0.4 | 0.5 | |
| 0.3 | 0.9 | 1.3 | −4.9 | |
| 5.6 | 14.6 | 16 | 15 |
Cash flow
| ₹ Cr | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 0.5 | −0.6 | 2.3 | 0.7 | |
| −3.4 | −9 | −2.4 | −0.6 | |
| 4.9 | 8.4 | −0.3 | – | |
| 2 | −1.2 | −0.4 | 0.1 | |
| −1.4 | −1 | −6.9 | −6.6 | |
| −0.8 | −1.6 | −4.7 | −5.9 | |
| – | – | −0.3 | – |
Shareholding pattern
This company is listed only on BSE, so there’s no NSE category split. See Major shareholders below for the named holders.
Major shareholders
Filings & events
News
No recent news coverage found.